U.S. FDA says carcinogen not found in alternatives of Zantac and its generics

U.S. FDA says carcinogen not found in alternatives of Zantac and its generics
Reuters: Health
U.S. retailers Walmart Inc, CVS Health Corp Walgreens Boots Alliance Inc and Rite Aid Corp have all removed Zantac off their shelves after some drugs containing its key ingredient ranitidine were found to have traces of the impurity, N-nitrosodimethylamine (NDMA).